Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Transitional Cell
  • Urologic Neoplasms

abstract

  • The presence of baseline KPS less than 80% or visceral metastasis has an impact on survival. Reporting the proportion of patients with zero, one, and two risk factors will facilitate understanding of the relevance of the median survival in phase II trials. Phase III trials should stratify patients according to the number of risk factors to avoid imbalance in treatment arms.

publication date

  • October 1999

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 10506615

Additional Document Info

start page

  • 3173

end page

  • 81

volume

  • 17

number

  • 10